NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific institutional responses may be helpful to others. Therefore, we are expeditiously providing documents and recommendations developed by NCCN Member Institutions or Guideline Panels as resources for oncology care providers.  These resources have not been developed or reviewed by the standard NCCN processes, and are provided for informational purposes only. We will post more resources as they become available. Please check back for additional updates.

COVID-19 Vaccination and Cancer Patients

NCCN has recently formed a COVID-19 Vaccine Committee including top hematology and oncology experts with particular expertise in infectious diseases, vaccination development, medical ethics, and health information technology. This committee has established recommendations that can help cancer care providers make informed decisions on how to protect their patients from the ongoing COVID-19 pandemic, based on available evidence plus expert consensus. This information is being continually updated as more vaccine options become available.

Download Recommendations

Any submissions related to the vaccination recommendations are reviewed by the NCCN Covid-19 Vaccination Advisory Committee.

Submission by Janssen Pharmaceutical Companies of Johnson & Johnson on 04/09/2021

Cancer Won't Wait And Neither Should You

NCCN and ACS are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. A coalition of 76 organizations have signed a letter to the public about the significant threat cancer poses to people's health.

Learn More